IRWD 4.52 (+0.89%)
US46333X1081Drug ManufacturersDrug Manufacturers - Specialty & Generic

Ironwood Pharmaceuticals (IRWD) Stock Highlights

4.52 | +0.89%
2024-09-19 03:54:35
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Statistics

Range Today
4.47 4.76
Volume Today 1.36M
Range 1 Year
3.79 15.7
Volume 1 Year 747.7M
Range 3 Year
3.79 15.7
Volume 3 Year 1.94B
Range 10 Year
3.79 17.7554
Volume 10 Year 4.87B

Highlights

Market Capitalization 730.01M (small)
Floating Shares 131.89M
Current Price 4.52
Price To Earnings 57.63
Price To Revenue 3.14
Earnings Per Share 0.08
Payout Ratio 0%

Performance

Latest +0.89%
1 Month +4.63%
3 Months -21.39%
6 Months -49.27%
1 Year -46.32%
3 Years -62.92%
5 Years -53.21%
10 Years -57.07%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.